Parsons L - Search Results

1

Etiology and susceptibility of urinary tract isolates in Kosova.

Raka L, Mulliqi-Osmani G, Berisha L, Begolli L, Omeragiq S, Parsons L, Salfinger M, Jaka A, Kurti A, Jakupi X. Raka L, et al. Among authors: parsons l. Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S2-5. doi: 10.1016/j.ijantimicag.2003.09.009. Int J Antimicrob Agents. 2004. PMID: 15037322

2

Analysis of tuberculosis surveillance in Hungary in 2000.

Mester J, Vadász I, Pataki G, Parsons L, Fodor T, Salfinger M, Somoskövi A. Mester J, et al. Among authors: parsons l. Int J Tuberc Lung Dis. 2002 Nov;6(11):966-73. Int J Tuberc Lung Dis. 2002. PMID: 12475142

3

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW. Parsons LM, et al. Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25. doi: 10.1128/AAC.49.6.2218-2225.2005. Antimicrob Agents Chemother. 2005. PMID: 15917515 Free PMC article.

4

Laboratory diagnosis of nontuberculous mycobacteria.

Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M. Somoskovi A, et al. Clin Chest Med. 2002 Sep;23(3):585-97. doi: 10.1016/s0272-5231(02)00018-7. Clin Chest Med. 2002. PMID: 12370994 Review.

5

Laboratory diagnostic aspects of drug resistant tuberculosis.

Parsons LM, Somoskövi A, Urbanczik R, Salfinger M. Parsons LM, et al. Front Biosci. 2004 Sep 1;9:2086-105. doi: 10.2741/1290. Front Biosci. 2004. PMID: 15353272 Review.

6

Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.

Somoskovi A, Song Q, Mester J, Tanner C, Hale YM, Parsons LM, Salfinger M. Somoskovi A, et al. J Clin Microbiol. 2003 Jul;41(7):2822-6. doi: 10.1128/JCM.41.7.2822-2826.2003. J Clin Microbiol. 2003. PMID: 12843007 Free PMC article.

7

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.

Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL. Gumbo T, et al. Among authors: parsons lm. Antimicrob Agents Chemother. 2007 Nov;51(11):3781-8. doi: 10.1128/AAC.01533-06. Epub 2007 Aug 27. Antimicrob Agents Chemother. 2007. PMID: 17724157 Free PMC article.

8

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Somoskovi A, Parsons LM, Salfinger M. Somoskovi A, et al. Among authors: parsons lm. Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5. Respir Res. 2001. PMID: 11686881 Free PMC article. Review.

9

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

Gumbo T, Louie A, Deziel MR, Parsons LM, Salfinger M, Drusano GL. Gumbo T, et al. Among authors: parsons lm. J Infect Dis. 2004 Nov 1;190(9):1642-51. doi: 10.1086/424849. Epub 2004 Sep 24. J Infect Dis. 2004. PMID: 15478070

10

Drug resistance in tuberculosis.

Parsons LM, Driscoll JR, Taber HW, Salfinger M. Parsons LM, et al. Infect Dis Clin North Am. 1997 Dec;11(4):905-28. doi: 10.1016/s0891-5520(05)70397-4. Infect Dis Clin North Am. 1997. PMID: 9421707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

794 results

Search Page

Filters